New Zealand markets open in 20 minutes

Hangzhou Tigermed Consulting Co., Ltd (3347.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
27.600-1.000 (-3.50%)
At close: 04:08PM HKT

Hangzhou Tigermed Consulting Co., Ltd

Shengda Science Park
Building A, Floor 18 No.19 Jugong Road Binjiang District
Hangzhou 310051
China
86 571 2888 7227
https://www.tigermedgrp.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees9,701

Key executives

NameTitlePayExercisedYear born
Dr. Xiaoping Ye D.Phil, EMBA, M.D., Ph.D.Co-Founder & ChairmanN/AN/A1963
Dr. Xiaochun Cao M.D.Co-Founder, GM & Executive DirectorN/AN/A1969
Mr. Hao WuPresident & Executive DirectorN/AN/A1967
Ms. Chengcheng YangChief Financial OfficerN/AN/A1974
Mr. Zengyu WenExecutive VP, COO & Executive DirectorN/AN/A1980
Ms. Xiao Ri LiSecretaryN/AN/A1983
Dr. Tianrong Ji M.D., Ph.D.Chief Investment OfficerN/AN/AN/A
Mr. Guoyun YuHead of Accounting DepartmentN/AN/AN/A
Mr. Jiansong Yang Ph.D.Senior VP & Chief Scientific OfficerN/AN/AN/A
Mr. Alan LiuChief Compliance OfficerN/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Corporate governance

Hangzhou Tigermed Consulting Co., Ltd’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.